WHO’s 2026 TB Report Highlights a Persistent Funding Shortfall
The World Health Organization’s new tuberculosis report says financing remains far below international targets despite increased domestic investment in several countries. Follow HilluBhai news for more updates.
Key details
| Item | Details |
|---|---|
| Report released | November 12, 2026 |
| 2025 TB service funding in LMICs | US$6.6 billion |
| 2027 annual commitment | US$22 billion |
| Domestic share of 2025 funding | 86% |
The gap behind the headline
WHO’s financing material says available funding for prevention, diagnosis, treatment and care in low- and middle-income countries reached only about 30% of the annual commitment. Domestic financing increased, while international donor support declined in 2025.
Progress and unfinished work
The report estimates that 10.6 million people developed TB in 2025 and 1.13 million died. WHO notes that progress in reducing disease remains too slow and that diagnosis and treatment gaps persist. These figures refer to 2025, not cases newly counted during November 2026.
Why sustainable funding matters
Funding supports continuity: diagnostic capacity, staff, medicines and follow-up must work together over time. A larger budget announcement and reliable access to services are related but different measures of progress. WHO also cautions that burden estimates should be compared using the latest time series rather than mixing headline estimates from different annual editions. This is a report on public-health financing, not individual diagnosis or treatment advice.
Reporting basis: WHO Global Tuberculosis Report 2026, financing fact sheet and report overview, November 12, 2026.
Post Comment